Corticosteroids during pregnancy and oral clefts: A case-control study

Teratology

Volumn 58, Issue 1, 1998, Pages 2-5

  Rodríguez Pinilla, Elvira ^a   Martínez Frías, M Luisa ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CORTICOSTEROID; METRONIDAZOLE; SEX HORMONE;

ARTICLE; CLEFT LIP; CONTROLLED STUDY; FAMILY HISTORY; FIRST TRIMESTER PREGNANCY; HUMAN; HYPERTHERMIA; MAJOR CLINICAL STUDY; NEWBORN; PREGNANCY DISORDER; PRIORITY JOURNAL; REGRESSION ANALYSIS; SMOKING;

ADRENAL CORTEX HORMONES; CASE-CONTROL STUDIES; CLEFT LIP; CLEFT PALATE; FEMALE; HUMANS; INFANT, NEWBORN; LOGISTIC MODELS; ODDS RATIO; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL EXPOSURE DELAYED EFFECTS; SPAIN;

EID: 0031689424     PISSN: 00403709     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9926(199807)58:1<2::AID-TERA2>3.0.CO;2-4     Document Type: Article

References (16)

1. ATC Classification. Guidelines for ATC Classification (1990) WHO Collaborating Centre for Drug Statistic Methodology. Sweden: Norway and Nordic Council on Medicines.
2. Czeizel, A.E., and M. Rockenbauer (1997) Population-based case-control study of teratogenic potential of corticosteroids. Teratology, 56:335-340.
3. Doig, R.K., and O. McK. Coltman (1956) Cleft palate following cortisone therapy in early pregnancy. Lancet, 2:730.
4. Fraser, F.C., and T.D. Fainstat (1951) The production of congenital defects in the offspring of pregnant mice treated with cortisone: A progress report. Pediatrics, 8:527-533.
5. Fraser, F.C., and A. Sajoo (1995) Teratogenic potential of corticosteroids in humans. Teratology, 51:45-46.
6. Harris, J.W.S., and I.P. Ross (1956) Cortisone therapy in early pregnancy: Relation to cleft palate. Lancet, 1:1045-1047.
7. ICBDMS (International Clearinghouse for Birth Defects Monitoring Systems) (1996) Annual Report. Published by International Centre for Birth Defects.
8. Khoury M.J., L.M. James, D. Flanders, and J.D. Erickson (1992) Interpretation of recurring weak associations obtained from epidemiologic studies of suspected human teratogens. Teratology, 46: 69-77.
9. Kullander, S., and B. Källén (1976) A prospective study of drugs and pregnancy. Acta Obstet. Gynecol. Scand., 55:221-224.
10. Martínez-Frías, M.L. (1993) Interviewer bias and maternal bias. Teratology, 47:531-532.
11. Martínez-Frías, M.L. (1995) Primary midline developmental field. I. Clinical and epidemiological characteristics. Am. J. Med. Genet., 56:374-381.
12. Martínez-Frías, ML., J.L. Frías, E. Rodríguez-Pinilla, M. Urioste, E. Bermejo, A. Cereijo, and F. Gaya (1991) Value of clinical analysis in epidemiological research: the Spanish registry experience. Am. J. Med. Genet., 41:192-195.
13. Robert E., S.E. Vollset, L. Botto, P.A.L. Lancaster, P. Merlob, G. Cocchi, M. Ashizawa, S. Sakamoto, and I. Orioli (1994) Malformation surveillance and maternal drug exposure: the MADRE project. Risk Safety Med., 6:78-118.
14. Rothman, K.J. (1986) Modern Epidemiology. Boston: Little, Brown.
15. Schatz, M., R. Patterson, S. Zeitz, J. O'Rourke, and H. Melam (1975) Corticosteroid therapy for the pregnant asthmatic patient. JAMA, 233:804-807.
16. Shepard, T.H. (1994) "Proof" of human teratogenicity. Teratology, 50:97-98.